Literature DB >> 6280965

Thyroid hormone specifically inhibits prolactin synthesis and decreases prolactin messenger ribonucleic acid levels in cultured pituitary cells.

R A Maurer.   

Abstract

Electrophoretic analysis of soluble proteins from pituitary cells pulse labeled with [35S]methionine demonstrated that 10 nM T3 inhibited PRL synthesis, but did not affect the synthesis of most other pituitary proteins. The effects of T3 were somewhat slow, requiring about 3 days for a 50% reduction in PRL synthesis. PRL synthesis slowly returned toward control levels after the removal of T3 from the culture medium. In serum-free medium, a concentration of about 0.6 nM T3 was required for half-maximal inhibition of PRL synthesis. In medium containing 5% fetal calf serum, only slightly higher concentrations of T3 were required to inhibit PRL synthesis. The Kd for the binding of [125]T3 to pituitary cell nuclei was 0.2 nM. Analysis of PRL mRNA levels by hybridization of total cellular RNA to PRL cDNA demonstrated that there was a good correspondence between T3 effects on PRL synthesis and PRL mRNA. These findings demonstrate that T3 can specifically inhibit PRL synthesis and PRL mRNA levels in cultured pituitary cells and suggest that T3 may have a physiological role in the regulation of PRL synthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280965     DOI: 10.1210/endo-110-5-1507

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Reconstitution of cell-type-specific transcription of the rat prolactin gene in vitro.

Authors:  Z D Cao; E A Barron; A J Carillo; Z D Sharp
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Modulations of prolactin and growth hormone gene expression and chromatin structure in cultured rat pituitary cells.

Authors:  B Levy-Wilson
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971

4.  Detection of two chromatin proteins which bind specifically to the 5'-flanking region of the rat prolactin gene.

Authors:  B A White; G M Preston; T C Lufkin; C Bancroft
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

5.  Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter.

Authors:  G Radetti; S Bernasconi; M Bozzola; C Volta; G Tonini; L Gentili; F Rigon
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

6.  Morphofunctional study on prolactin-producing cells of the anterior pituitaries in adult male rats following thyroidectomy, thyroxine treatment and/or thyrotropin-releasing hormone treatment.

Authors:  H Ozawa; K Kurosumi
Journal:  Cell Tissue Res       Date:  1993-04       Impact factor: 5.249

7.  Prolactin upstream factor I mediates cell-specific transcription.

Authors:  Z D Cao; E A Barron; Z D Sharp
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

8.  TRH: pathophysiologic and clinical implications.

Authors:  C R Pickardt; P C Scriba
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  Inverse control of prolactin and growth hormone gene expression: effect of thyroliberin on transcription and RNA stabilization.

Authors:  J N Laverriere; A Morin; A Tixier-Vidal; A T Truong; D Gourdji; J A Martial
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Isolation and characterization of the human prolactin gene.

Authors:  A T Truong; C Duez; A Belayew; A Renard; R Pictet; G I Bell; J A Martial
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.